期刊
CANCERS
卷 15, 期 17, 页码 -出版社
MDPI
DOI: 10.3390/cancers15174242
关键词
early-onset colorectal cancer; COVID-19 pandemic; prognosis
类别
The rising incidence of colorectal cancer (CRC) among young patients is alarming. This study included all patients with pathologically confirmed diagnoses of CRC at Hospital Universitario La Paz from October 2016 to December 2021. Among the 1475 CRC patients, 80 (5.4%) had early-onset CRC (EOCRC). EOCRC had more aggressive pathological features and higher prevalence of certain characteristics compared to later-onset CRC. Metastatic EOCRC patients had significantly longer overall survival (OS) than the older cohort. More patients with COVID-19 were diagnosed with metastatic disease after the lockdown.
Simple Summary The rising incidence of colorectal cancer (CRC) among young patients (& LE;50 years) is alarming. We included all patients with pathologically confirmed diagnoses of CRC at Hospital Universitario La Paz from October 2016 to December 2021. A total of 1475 patients diagnosed with CRC were included, eighty (5.4%) of whom had EOCRC. Aggressive pathological features, such as T, N stage and metastatic presentation at diagnosis; perineural invasion; tumor budding; high-grade tumors; and signet ring cell histology, were higher in the early-onset group. Patients with metastatic EOCRC HAD a significantly longer median OS than the older cohort. Regarding COVID-19 pandemic, more patients with COVID-19 were diagnosed with metastatic disease (61%) after the lockdown. The long-term consequences of COVID-19 are yet to be determined.Abstract Background: The rising incidence of colorectal cancer (CRC) among young patients is alarming. We aim to characterize the clinico-pathological features and outcomes of patients with early-onset CRC (EOCRC), as well as the impacts of COVID-19 pandemic. Methods: We included all patients with pathologically confirmed diagnoses of CRC at Hospital Universitario La Paz from October 2016 to December 2021. The EOCRC cut-off age was 50 years old. Results: A total of 1475 patients diagnosed with CRC were included, eighty (5.4%) of whom had EOCRC. Significant differences were found between EOCRC and later-onset patients regarding T, N stage and metastatic presentation at diagnosis; perineural invasion; tumor budding; high-grade tumors; and signet ring cell histology, with all issues having higher prevalence in the early-onset group. More EOCRC patients had the RAS/ BRAF wild type. Chemotherapy was administered more frequently to patients with EOCRC. In the metastatic setting, the EOCRC group presented a significantly longer median OS. Regarding the COVID-19 pandemic, more patients with COVID-19 were diagnosed with metastatic disease (61%) in the year after the lockdown (14 March 2020) than in the pre-pandemic EOCRC group (29%). Conclusions: EOCRC is diagnosed at a more advanced stage and with worse survival features in localized patients. More patients with EOCRC were diagnosed with metastatic disease in the year after the COVID-19 pandemic lockdown. The long-term consequences of COVID-19 are yet to be determined.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据